These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38658095)
1. Repurposing diacerein to suppress colorectal cancer growth by inhibiting the DCLK1/STAT3 signaling pathway. Ye Q; Zhu Y; Shi M; Lv L; Gong Y; Zhang L; Yang L; Zhao H; Zhao C; Xu H Chin J Nat Med; 2024 Apr; 22(4):318-328. PubMed ID: 38658095 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1. Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010 [TBL] [Abstract][Full Text] [Related]
3. Targeting DCLK1 overcomes 5-fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β-catenin pathway-mediated cancer stemness. Wang L; Zhao L; Lin Z; Yu D; Jin M; Zhou P; Ren J; Cheng J; Yang K; Wu G; Zhang T; Zhang D Clin Transl Med; 2022 May; 12(5):e743. PubMed ID: 35522902 [TBL] [Abstract][Full Text] [Related]
4. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer. Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285 [TBL] [Abstract][Full Text] [Related]
5. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1. Weygant N; Qu D; Berry WL; May R; Chandrakesan P; Owen DB; Sureban SM; Ali N; Janknecht R; Houchen CW Mol Cancer; 2014 May; 13():103. PubMed ID: 24885928 [TBL] [Abstract][Full Text] [Related]
6. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway. Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091 [TBL] [Abstract][Full Text] [Related]
7. Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway. Yang L; Yao Y; Bai Y; Zheng D; Zhou F; Chen L; Hu W; Xiang Y; Zhao H; Liu Z; Wang L; Huang X; Zhao C Phytomedicine; 2021 Jan; 80():153366. PubMed ID: 33080566 [TBL] [Abstract][Full Text] [Related]
8. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer. Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989 [TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway. He T; Cui J; Wu Y; Sun X; Chen N Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness. Park SY; Kim JY; Choi JH; Kim JH; Lee CJ; Singh P; Sarkar S; Baek JH; Nam JS Clin Cancer Res; 2019 Feb; 25(4):1415-1429. PubMed ID: 30446587 [TBL] [Abstract][Full Text] [Related]
12. DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis. Kim JH; Park SY; Jeon SE; Choi JH; Lee CJ; Jang TY; Yun HJ; Lee Y; Kim P; Cho SH; Lee JS; Nam JS Theranostics; 2022; 12(12):5258-5271. PubMed ID: 35910805 [No Abstract] [Full Text] [Related]
13. Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells. Kawamura D; Takemoto Y; Nishimoto A; Ueno K; Hosoyama T; Shirasawa B; Tanaka T; Kugimiya N; Harada E; Hamano K Oncol Rep; 2017 Nov; 38(5):3238-3244. PubMed ID: 29048622 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer. Ji D; Zhan T; Li M; Yao Y; Jia J; Yi H; Qiao M; Xia J; Zhang Z; Ding H; Song C; Han Y; Gu J Stem Cell Reports; 2018 Dec; 11(6):1506-1522. PubMed ID: 30449704 [TBL] [Abstract][Full Text] [Related]
15. Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling. Liu H; Yan R; Xiao Z; Huang X; Yao J; Liu J; An G; Ge Y Breast Cancer Res; 2023 Apr; 25(1):43. PubMed ID: 37069669 [TBL] [Abstract][Full Text] [Related]
16. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer. Liu W; Wang S; Sun Q; Yang Z; Liu M; Tang H Int J Cancer; 2018 May; 142(10):2068-2079. PubMed ID: 29277893 [TBL] [Abstract][Full Text] [Related]
17. Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway. Yang L; Zhu T; Ye H; Shen Y; Li Z; Chen L; Wang C; Chen X; Zhao H; Xiang Y; Xiao Z; Zhao C; Li J; Hu W J Cell Mol Med; 2021 Jan; 25(2):801-812. PubMed ID: 33259114 [TBL] [Abstract][Full Text] [Related]
18. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells. Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261 [TBL] [Abstract][Full Text] [Related]
19. Induction of let-7e gene expression attenuates oncogenic phenotype in HCT-116 colorectal cancer cells through targeting of DCLK1 regulation. Khodadadi Kohlan A; Saidijam M; Amini R; Samadi P; Najafi R Life Sci; 2019 Jul; 228():221-227. PubMed ID: 31075231 [TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer. Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]